We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$5.3M
Turnover
85.61%
1-Year Est. Return
7.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.09%
1 Year Est. Return
+7.8%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.86M
AUM Growth
-$188M
(-95%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-1,882.29%
Top 10 Holdings %
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611
Avg Time Held
0.3
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACV Auctions
ACVA
|
+$194K |
| 2 |
Rapid7
RPD
|
+$183K |
| 3 |
Ellington Financial
EFC
|
+$181K |
| 4 |
Banco Santander
SAN
|
+$159K |
| 5 |
Oscar Health
OSCR
|
+$155K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXL Service
EXLS
|
+$830K |
| 2 |
Delek US
DK
|
+$724K |
| 3 |
Broadcom
AVGO
|
+$669K |
| 4 |
Itron
ITRI
|
+$666K |
| 5 |
Brinker International
EAT
|
+$649K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.83% |
| 2 | Technology | 15.87% |
| 3 | Healthcare | 10.98% |
| 4 | Industrials | 10.86% |
| 5 | Real Estate | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Cognyte Software
CGNT
$636M
| – | – |
-27,706
| Closed | -$260K | – |
|
202
Cognex
CGNX
$9.08B
| – | – |
-10,696
| Closed | -$385K | – |
|
203
Choice Hotels
CHH
$4.88B
| – | – |
-3,282
| Closed | -$313K | – |
|
204
Cigna
CI
$79.9B
| – | – |
-1,258
| Closed | -$346K | – |
|
205
Ciena
CIEN
$47.2B
| – | – |
-1,044
| Closed | -$244K | – |
|
|
CIO
206
DELISTED
City Office REIT
CIO
| – | – |
-46,164
| Closed | -$323K | – |
|
207
CION Investment
CION
$324M
| – | – |
-17,485
| Closed | -$169K | – |
|
208
Climb Global Solutions
CLMB
$595M
| – | – |
-10,568
| Closed | -$272K | – |
|
209
CleanSpark
CLSK
$2.16B
| – | – |
-24,027
| Closed | -$243K | – |
|
210
Clorox
CLX
$10.5B
| – | – |
-2,082
| Closed | -$210K | – |
|
211
Comcast
CMCSA
$77.7B
| – | – |
-9,809
| Closed | -$293K | – |
|
212
Cummins
CMI
$73.1B
| – | – |
-594
| Closed | -$303K | – |
|
213
Compass Minerals
CMP
$934M
| – | – |
-13,003
| Closed | -$255K | – |
|
214
Cimpress
CMPR
$1.86B
| – | – |
-3,885
| Closed | -$259K | – |
|
215
Centene
CNC
$34.2B
| – | – |
-9,774
| Closed | -$402K | – |
|
216
Canadian National Railway
CNI
$73.6B
| – | – |
-2,219
| Closed | -$219K | – |
|
217
Core & Main
CNM
$7.74B
| – | – |
-3,851
| Closed | -$200K | – |
|
218
Cohen & Steers
CNS
$3.58B
| – | – |
-4,254
| Closed | -$267K | – |
|
219
PC Connection
CNXN
$2.25B
| – | – |
-4,824
| Closed | -$279K | – |
|
220
Capital One
COF
$124B
| – | – |
-923
| Closed | -$224K | – |
|
221
Americold
COLD
$3.95B
| – | – |
-40,714
| Closed | -$524K | – |
|
222
Vistance Networks Inc
VISN
$1.34B
| – | – |
-22,174
| Closed | -$402K | – |
|
223
Coursera
COUR
$1.31B
| – | – |
-33,353
| Closed | -$245K | – |
|
224
Coty
COTY
$2.82B
| – | – |
-51,690
| Closed | -$159K | – |
|
225
Costco
COST
$438B
| – | – |
-533
| Closed | -$460K | – |
|
Similar funds
SA
BP
WI
PFGWM
BM
OFC
AL
WH
PharVision Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.
- PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
- PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
- PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
- PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
- PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
- PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
- PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.